1
|
Fantone M, Broner J, Dumain C, Fesler P, Arnaud E, Gaujoux-Viala C, Jeanjean L, Goulabchand R. Étude des évènements cortico-induits chez des patients atteints d’Uvéite Chronique Non Infectieuse. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.03.299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
2
|
Petit B, Soudry-Faure A, Jeanjean L, Foucher J, Lalanne L, Carpentier M, Jonval L, Allard C, Ravier M, Mohamed AB, Meille V, Trojak B. Efficacy of repetitive transcranial magnetic stimulation (rTMS) for reducing consumption in patients with alcohol use disorders (ALCOSTIM): study protocol for a randomized controlled trial. Trials 2022; 23:33. [PMID: 35022086 PMCID: PMC8756711 DOI: 10.1186/s13063-021-05940-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2021] [Accepted: 12/15/2021] [Indexed: 11/12/2022] Open
Abstract
Background The number of people with an alcohol use disorder (AUD) was recently estimated to be 63.5 million worldwide. The global burden of disease and injury attributable to alcohol is considerable: about 3 million deaths, namely one in 20, were caused by alcohol in 2015. At the same time, AUD remains seriously undertreated. In this context, alternative or adjunctive therapies such as brain stimulation could play an important role. The early results of studies using repetitive transcranial magnetic stimulation (rTMS) suggest that stimulations delivered to the dorsolateral prefrontal cortex significantly reduce cravings and improve decision-making processes in various addictive disorders. We therefore hypothesize that rTMS could lead to a decrease in alcohol consumption in patients with AUD. Methods/design We report the protocol of a randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy of rTMS on alcohol reduction in individuals diagnosed with AUD. The study will be conducted in 2 centers in France. Altogether, 144 subjects older than 18 years and diagnosed with AUD will be randomized to receive 5 consecutive twice-daily sessions of either active or sham rTMS (10 Hz over the right DLPFC, 2000 pulses per day). The main outcomes of the study will be changes in alcohol consumption within the 4 weeks after the rTMS sessions. Secondary outcome measures will include changes in alcohol consumption within the 24 weeks, alcohol cravings, clinical and biological improvements, effects on mood and quality of life, and cognitive and safety assessments, and, for smokers, an assessment of the effects of rTMS on tobacco consumption. Discussion Several studies have observed a beneficial effect of rTMS on substance use disorders by reducing craving, impulsivity, and risk-taking behavior and suggest that rTMS may be a promising treatment in addiction. However, to date, no studies have included sufficiently large samples and sufficient follow-up to confirm this hypothesis. The results from this large randomized controlled trial will give a better overview of the therapeutic potential of rTMS in AUD. Trial registration ClinicalTrials.gov NCT04773691. Registered on 26 February 2021 https://clinicaltrials.gov/ct2/show/NCT04773691?term=trojak&draw=2&rank=5.
Collapse
Affiliation(s)
- Benjamin Petit
- Department of Addictology, University Hospital of Dijon, 14 rue Paul Gaffarel, B.P. 77908, 21079, Dijon Cedex, France. .,UFR des Sciences de Santé, Université de Bourgogne, Dijon, France.
| | - Agnès Soudry-Faure
- Unité de Soutien Méthodologique à la Recherche, Délégation à la Recherche et à l'Innovation (DRCI), University Hospital of Dijon, 1 boulevard Jeanne d'Arc BP 77 908, 21 079, Dijon Cedex, France
| | - Ludovic Jeanjean
- UMR CNRS 7357 iCube, FMTS (Fédération de Médecine Translationnelle de Strasbourg), Université de Strasbourg, Strasbourg, France.,Centre de neuroModulation Non-Invasive de Strasbourg - CEMNIS, Hôpitaux Universitaires de Strasbourg, Hôpital Civil, 1 place de l'Hopital, BP426, 67091, Strasbourg Cedex, France
| | - Jack Foucher
- UMR CNRS 7357 iCube, FMTS (Fédération de Médecine Translationnelle de Strasbourg), Université de Strasbourg, Strasbourg, France.,Centre de neuroModulation Non-Invasive de Strasbourg - CEMNIS, Hôpitaux Universitaires de Strasbourg, Hôpital Civil, 1 place de l'Hopital, BP426, 67091, Strasbourg Cedex, France
| | - Laurence Lalanne
- INSERM 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), 67000, Strasbourg, France.,Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), 67000, Strasbourg, France.,Pôle Psychiatrie, Santé Mentale et Addictologie, Clinique de psychiatrie, Hôpitaux Universitaires de Strasbourg, 1 place de l'hôpital, BP 426, F-67091, Strasbourg Cedex, France
| | - Maud Carpentier
- Délégation à la Recherche et à l'Innovation (DRCI), University Hospital of Dijon, 1 boulevard Jeanne d'Arc - BP 77 908, 21079, Dijon Cedex, France
| | - Lysiane Jonval
- Unité de Soutien Méthodologique à la Recherche, Délégation à la Recherche et à l'Innovation (DRCI), University Hospital of Dijon, 1 boulevard Jeanne d'Arc BP 77 908, 21 079, Dijon Cedex, France
| | - Coralie Allard
- Department of Addictology, University Hospital of Dijon, 14 rue Paul Gaffarel, B.P. 77908, 21079, Dijon Cedex, France.,Délégation à la Recherche et à l'Innovation (DRCI), University Hospital of Dijon, 1 boulevard Jeanne d'Arc - BP 77 908, 21079, Dijon Cedex, France
| | - Mathilde Ravier
- Department of Addictology, University Hospital of Dijon, 14 rue Paul Gaffarel, B.P. 77908, 21079, Dijon Cedex, France
| | - Amine Ben Mohamed
- Délégation à la Recherche et à l'Innovation (DRCI), University Hospital of Dijon, 1 boulevard Jeanne d'Arc - BP 77 908, 21079, Dijon Cedex, France
| | - Vincent Meille
- Department of Addictology, University Hospital of Dijon, 14 rue Paul Gaffarel, B.P. 77908, 21079, Dijon Cedex, France
| | - Benoit Trojak
- Department of Addictology, University Hospital of Dijon, 14 rue Paul Gaffarel, B.P. 77908, 21079, Dijon Cedex, France.,UFR des Sciences de Santé, Université de Bourgogne, Dijon, France.,INSERM UMR1093-CAPS, Université Bourgogne Franche-Comté, UFR des Sciences du Sport, Dijon, France
| |
Collapse
|
3
|
Jeanjean L, Lucas X, Daien V, Chevallier T, Daures J, De Mattei C, Dupeyron G. Validation du bilan 13–30 ARAMAV, un nouveau questionnaire de qualité de vie et d’autonomie adapté aux patients déficients visuels. J Fr Ophtalmol 2020; 43:742-752. [DOI: 10.1016/j.jfo.2019.10.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2019] [Revised: 09/24/2019] [Accepted: 10/21/2019] [Indexed: 11/28/2022]
|
4
|
Duval F, Mokrani MC, Erb A, Danila V, Gonzalez Lopera F, Jeanjean L. Dopaminergic, Noradrenergic, Adrenal, and Thyroid Abnormalities in Psychotic and Affective Disorders. Front Psychiatry 2020; 11:533872. [PMID: 33101075 PMCID: PMC7546351 DOI: 10.3389/fpsyt.2020.533872] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2020] [Accepted: 09/03/2020] [Indexed: 12/02/2022] Open
Abstract
BACKGROUND This study aimed to assess hypothalamic-pituitary dopaminergic (DA), noradrenergic (NA), thyroid (HPT), and adrenal (HPA) activity in schizophrenia, in schizoaffective disorder, and in bipolar disorder. METHOD We investigated a combined approach of hormone responses to (1) apomorphine (APO), a short-acting DA receptor agonist which decreases prolactin secretion (PRL), and stimulates secretion of growth hormone (GH), adrenocorticotropin (ACTH), and cortisol; (2) clonidine (CLO), an alpha 2-adrenoceptor agonist which stimulates GH secretion; (3) 8 AM and 11 PM protirelin (TRH) which stimulates thyrotropin (TSH) secretion; and (4) dexamethasone which suppresses cortisol secretion, in 13 hospitalized healthy male controls and 39 untreated male inpatients: 13 with DSM-IV paranoid schizophrenia, 13 with DSM-IV schizoaffective disorder (bipolar subtype, depressed at the time of the study), and 13 with DSM-IV bipolar disorder (depressed). RESULTS Compared to controls, paranoid schizophrenic patients showed (1) lower APO-induced ACTH and cortisol stimulation, and (2) higher post-dexamethasone cortisol values. Compared to controls, schizoaffective and bipolar patients showed (1) lower ΔΔTSH values (i.e., difference between 11 PM and 8 AM TRH-TSH responses), (2) lower APO-induced PRL suppression, (3) lower CLO-induced GH stimulation, and (4) higher post-dexamethasone cortisol values. CONCLUSIONS Although results must be interpreted with caution because of the small sample, this preliminary study suggests that depressed bipolar and schizoaffective patients share common biological dysregulations, distinct from that of paranoid schizophrenic patients. From a pathophysiological viewpoint, paranoid schizophrenic patients can be characterized by hyposensitivity of the hypothalamic DA receptors (possibly resulting from an increase in presynaptic DA release) associated with increased HPA axis activity, while depressed bipolar and schizoaffective patients can be characterized by hyposensitivity of the pituitary TRH and DA-D2 receptors (possibly linked to the activation of the hypothalamic TRH and tuberoinfundibular DA neurons, respectively), together with subsensitive postsynaptic α2-adrenoreceptors at the hypothalamic level (possibly secondary to an erratic release of NA) and increased HPA axis activity.
Collapse
Affiliation(s)
- Fabrice Duval
- Pôle 8/9-APF2R, Centre Hospitalier, Rouffach, France
| | | | - Alexis Erb
- Pôle 8/9-APF2R, Centre Hospitalier, Rouffach, France
| | - Vlad Danila
- Pôle 8/9-APF2R, Centre Hospitalier, Rouffach, France
| | | | | |
Collapse
|
5
|
Nadal J, Galatoire O, Laouar K, Jeanjean L, Villain M, Audemard D, Daien V. Periorbital necrotizing fasciitis without initial trauma: A rare case report. J Fr Ophtalmol 2019; 42:e209-e211. [PMID: 30979555 DOI: 10.1016/j.jfo.2018.09.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2018] [Accepted: 09/20/2018] [Indexed: 10/27/2022]
Affiliation(s)
- J Nadal
- Department of ophthalmology, Nîmes university hospital, CHU de Nîmes, 4, rue du Pr-Debré, 30029 Nîmes cedex 9, France; I2FH, institut d'imagerie fonctionnelle humaine, Gui de Chauliac hospital, Montpellier university hospital center, 34295 Montpellier, France.
| | - O Galatoire
- Service de chirurgie plastique et reconstructrice ophtalmologique, Fondation Rothschild Paris, 75019 Paris, France
| | - K Laouar
- Department of ophthalmology, Nîmes university hospital, CHU de Nîmes, 4, rue du Pr-Debré, 30029 Nîmes cedex 9, France
| | - L Jeanjean
- Department of ophthalmology, Nîmes university hospital, CHU de Nîmes, 4, rue du Pr-Debré, 30029 Nîmes cedex 9, France
| | - M Villain
- Department of ophthalmology, Gui De Chauliac hospital, 34000 Montpellier, France
| | - D Audemard
- Department of ophthalmology, Nîmes university hospital, CHU de Nîmes, 4, rue du Pr-Debré, 30029 Nîmes cedex 9, France
| | - V Daien
- Department of ophthalmology, Gui De Chauliac hospital, 34000 Montpellier, France; Inserm, neuropsychiatry: epidemiological and clinical research, university Montpellier, 34090 Montpellier, France
| |
Collapse
|
6
|
Voisin H, Jeanjean L, Alfonsi N. [Bilateral disc edema following a severe systemic viral illness]. J Fr Ophtalmol 2017; 40:708-712. [PMID: 28916113 DOI: 10.1016/j.jfo.2017.03.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2017] [Revised: 03/16/2017] [Accepted: 03/17/2017] [Indexed: 11/24/2022]
Affiliation(s)
- H Voisin
- Centre hospitalier d'Ajaccio, 27, avenue Impératrice-Eugénie, 20000 Ajaccio, France.
| | - L Jeanjean
- Centre hospitalier d'Ajaccio, 27, avenue Impératrice-Eugénie, 20000 Ajaccio, France
| | - N Alfonsi
- Centre hospitalier d'Ajaccio, 27, avenue Impératrice-Eugénie, 20000 Ajaccio, France
| |
Collapse
|
7
|
Jeanjean L, Dupeyron G. Troubles visuels anorganiques. J Fr Ophtalmol 2014; 37:415-20. [DOI: 10.1016/j.jfo.2013.12.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2013] [Accepted: 12/09/2013] [Indexed: 11/29/2022]
|
8
|
Jeanjean L, Dupeyron G, Labauge P. Rééducation dans le syndrome de Benson. Rev Neurol (Paris) 2013. [DOI: 10.1016/j.neurol.2013.01.509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
9
|
Bouyon M, Collongues N, Zéphir H, Ballonzoli L, Jeanjean L, Lebrun C, Chanson J, Blanc F, Fleury M, Outteryck O, Defoort S, Labauge P, Vermersch P, Speeg C, De Seze J. Longitudinal follow-up of vision in a neuromyelitis optica cohort. Mult Scler 2013; 19:1320-2. [PMID: 23413296 DOI: 10.1177/1352458513476562] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Neuromyelitis optica (NMO) is an inflammatory disease associated with optic neuritis and myelitis. Recently, several studies showed that optical coherence tomography (OCT) could be an interesting method for the evaluation of disease severity; however, to date there are no studies with a longitudinal follow-up of visual function in NMO. The aim of this study was to assess the ability of OCT to evaluate the progression of visual dysfunction in NMO. PATIENTS AND METHODS A group of 30 NMO patients (thus, 60 eyes), comprised of 20 women and 10 men with a mean age of 43.7 +/- 12.3 years, were prospectively evaluated clinically and by a whole neuro-ophthalmological work-up, including: visual acuity (VA), fundoscopy, visual evoked potential (VEP), visual field (VF) and optical coherence tomography (OCT). All patients were tested at baseline (after a mean disease duration of 6.1 years) and after a mean time of follow-up of 18 months (range: 12-36 months). RESULTS Mean VA was similar at the two evaluation times (0.77 +/- 0.36 versus 0.77 +/- 0.35). The mean VF defect decreased slightly, but the difference was not significant (-5.9 +/- 1.3 dB versus -5.3 +/- 1.3 dB). In contrast, the mean retinal thickness seen on OCT decreased from 87.4 +/- 23.3 µm to 79.7 +/- 22.4 µm (p = 0.006). These modifications were only observed in eyes with a past or a recent history of optic neuritis (-15.1 µm; p < 0.001) and not in eyes without any history of optic neuritis (-2.4 µm; not significant). Also, they occurred independently of the occurrence of relapses (n = 13) and especially optic neuritis episodes; however, the number of optic neuritis episodes was low (n = 5). CONCLUSION OCT seems to be a more sensitive test than VA or VF for monitoring ophthalmological function in NMO and it seems to be helpful for the detection of infra-clinical episodes in patients with a past history of optic neuritis. Our results suggest that this easily performed technique should be used in the follow-up of NMO, but complementary studies are warranted to confirm its interest at an individual level.
Collapse
Affiliation(s)
- M Bouyon
- Department of Ophthalmology, Strasbourg University, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Bouillot P, Dimeglio V, Hladky JP, Dufour T, Jeanjean L, Campello C, Labauge P. Intérêt de l’OCT (tomographie en cohérence optique) dans la prise en charge des tumeurs cérébrales. Neurochirurgie 2010. [DOI: 10.1016/j.neuchi.2010.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
11
|
Renard D, Castelnovo G, Jeanjean L, Perrochia H, Brunel H, Labauge P. Teaching NeuroImage: Microangiopathic complications in pseudoxanthoma elasticum. Neurology 2008; 71:e69. [DOI: 10.1212/01.wnl.0000335934.11120.83] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
12
|
Arndt C, Labauge P, Speeg-Schatz C, Jeanjean L, Fleury M, Castelnovo G, Ballonzolli L, Blanc F, Carlander B, De Sèze J. [Recurrent inflammatory optic neuropathy]. J Fr Ophtalmol 2008; 31:363-7. [PMID: 18563035 DOI: 10.1016/s0181-5512(08)71430-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
PURPOSE To analyze clinical and paraclinical characteristics of recurrent isolated optic neuropathy. PATIENTS and method: In three university hospitals (Montpellier, Nimes, and Strasbourg), between October 2005 and September 2006, the charts of patients with corticosensitive recurrent isolated optic neuropathy and normal cerebral magnetic resonance imaging included prospectively were reviewed. The following parameters were analyzed: date of the first relapse, age at onset, duration at the time of inclusion, recurrence after steroid withdrawal, unilateral or bilateral involvement, number of relapses, visual acuity, retinal nerve fiber layer thickness, diagnostic workup, and long-term treatment with immunosuppressive or immunomodulatory drugs. RESULTS During the predefined period, 13 patients (11 women, 2 men; age, 17-54 years at onset) matched the inclusion criteria. Between two and six relapses of optic neuropathy were observed. The median duration was 4 years. In untreated patients (n=7), a significant (Spearman p=0.0156) inverse correlation was observed between visual acuity and duration of the disease; this correlation was not found in the group of patients (n=6) with long-term treatment (Spearman p=0.1032). CONCLUSION The progressive loss of vision over time in this retrospective study of recurrent isolated optic neuropathy could be related to axonal loss. A prospective cohort study is necessary to confirm this hypothesis and to evaluate the benefit of long-term treatment on this progression.
Collapse
Affiliation(s)
- C Arndt
- Service d'Ophtalmologie, Hôpital Gui de Chauliac, CHU, Montpellier.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
de Seze J, Arndt C, Jeanjean L, Zephir H, Blanc F, Labauge P, Bouyon M, Ballonzoli L, Fleury M, Vermersch P, Speeg C. Relapsing inflammatory optic neuritis: is it neuromyelitis optica? Neurology 2008; 70:2075-6. [PMID: 18505981 DOI: 10.1212/01.wnl.0000313375.20123.25] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- J de Seze
- Department of Neurology, Strasbourg University, France.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Jeanjean L, Castelnovo G, Carlander B, Villain M, Mura F, Dupeyron G, Labauge P. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects]. Rev Neurol (Paris) 2008; 164:927-34. [PMID: 18808761 DOI: 10.1016/j.neurol.2008.03.008] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2007] [Revised: 03/01/2008] [Accepted: 03/20/2008] [Indexed: 01/21/2023]
Abstract
INTRODUCTION Multiple sclerosis is a common disabling progressive neurological disorder. Axonal loss is thought to be a likely cause of persistent disability after a multiple sclerosis relapse. Retinal nerve fiber layer (RNFL) imaging by optical coherence tomography (OCT) seems to be a non-invasive way of detecting optical axonal loss following optic neuritis. OBJECTIVE To determine whether multiple sclerosis affects retinal nerve fiber layer measurements obtained with optical coherence tomography (OCT3-Carl Zeiss Meditec, Dublin, California, USA). MATERIAL AND METHODS Diagnosis of MS was based on the MacDonald criteria. The cohort was divided into two groups based on their clinical course (multiple sclerosis with [n=8; 16 eyes] or without [n=7; 14 eyes] optic neuritis antecedents). The disease-free controls were matched for age and gender (n=15; 30 eyes). Retinal nerve fiber layer thickness was measured using optical coherence tomography (OCT; fastRNFL and RNFL thickness software protocol). Visual acuity, visual field, color vision were also noted. RESULTS There were highly significant reductions (p<0.001) of retinal nerve fiber layer thickness in affected patients (with or without optic neuritis antecedents) compared with control eyes (fastRNFL and RNFL procedures). Visual acuity, visual field and color vision were globally less altered than OCT. There were no significant relationships among RNFL thickness and visual acuity, visual field, or color vision. CONCLUSION This study has demonstrated the anatomic changes of the retinal nerve fiber layer of patients with multiple sclerosis with optic neuritis antecedents. Thus axonal loss following optic neuritis can be detected with OCT. But the retinal nerve fiber layer of patients without optic neuritis is also thinner than disease-free controls so that chronic optic axonal loss can be frequent in multiple sclerosis. Additionally, OCT was more sensitive than the common ophthalmological explorations to detect optical nerve impairment during multiple sclerosis. Finally, we demonstrated that two procedures fastRNFL and RNFL could be used to detect optic nerve impairment.
Collapse
Affiliation(s)
- L Jeanjean
- Consultation de neuro-ophtalmologie, CHU Carémeau, place du Professeur-Debré, 30900 Nîmes, France.
| | | | | | | | | | | | | |
Collapse
|
15
|
Landragin N, Jeanjean L, Bouly S, Honnorat J, de Sèze J, Castelnovo G, Labauge P. [Devic disease associated with isolated spinal cord atrophy]. Rev Neurol (Paris) 2008; 163:1236-8. [PMID: 18355472 DOI: 10.1016/s0035-3787(07)78409-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Devic disease is a rare entity characterized by bilateral optic neuritis and transverse myelitis. Recently, recognition of antibody activity (Anti NMO) led to broaden the clinical and MR phenotype spectrum of this disease. This report is about a patient with spinal cord atrophy and bilateral optic neuritis, occurring more than 8 years after symptom onset.
Collapse
|
16
|
Jeanjean L, Godard A, Castelnovo G, Dupeyron G, Labauge P. Myosite orbitaire chez une femme enceinte : à propos d’un cas. Rev Neurol (Paris) 2007. [DOI: 10.1016/s0035-3787(07)90931-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|